What's in LMC Diabetes & Endocrinology Ltd.'s pipeline?

LMC Diabetes & Endocrinology Ltd. has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with LMC Diabetes & Endocrinology Ltd.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/lmc-diabetes-endocrinology-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

LMC Diabetes & Endocrinology Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LMC Diabetes & Endocrinology Ltd. pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Basal insulin glargine and lixisenatide	Basal insulin glargine and lixisenatide	marketed
150% bolus insulin correction	150% bolus insulin correction	marketed
SGLT2 inhibitor and DPP-4 inhibitor	SGLT2 inhibitor and DPP-4 inhibitor	marketed	SGLT2 inhibitor and DPP-4 inhibitor combination	SGLT2 (sodium-glucose cotransporter 2) and DPP-4 (dipeptidyl peptidase-4)	Diabetes

Therapeutic area mix

Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for LMC Diabetes & Endocrinology Ltd.:

Cite this brief

Drug Landscape (2026). LMC Diabetes & Endocrinology Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/lmc-diabetes-endocrinology-ltd. Accessed 2026-05-17.